Assessing human papillomavirus type 16 transforming vs productive infections in oral epithelia
Project Number1K99DE033483-01
Contact PI/Project LeaderJACKSON, ROBERT
Awardee OrganizationUNIVERSITY OF ARIZONA
Description
Abstract Text
Project Summary/Abstract
The goal of this K99/R00 application is to support and facilitate the transition of Dr. Robert Jackson’s
mentored postdoctoral research project to an independent research program focused on spatiotemporal
modeling of cancer-causing human papillomavirus (HPV) infection in human oral epithelia. HPVs are responsible
for 5% of all cancers worldwide. HPV causes genital cancers, but also an increasing number of oral cancers,
most often in the tonsils and caused by HPV16. In the United States, the rate of HPV-associated oral cancers
has surpassed cervical cancers and is considered an epidemic. HPV16 can transform host oral epithelial cells
and lead to oral cancer, most often arising in the tonsillar crypt, but its normal viral lifecycle is reliant on epithelial
differentiation to yield a productive infection. To address the oral health burden caused by HPV16, Dr. Jackson
proposes three specific aims to assess and characterize HPV16 transforming vs productive infections in oral
epithelia. Dr. Jackson’s preliminary work, using three-dimensional oral epithelial culture and single-cell
transcriptomics, demonstrates that tonsillar crypt and surface epithelial subtypes have unique differentiation
phenotypes and host regulator activity. In the K99 mentored phase, Dr. Jackson will assess HPV16’s lifecycle in
tonsil epithelial subtypes and test the hypothesis that a host transcription factor, Peroxisome Proliferator-
Activated Receptor Alpha (PPARα), regulates viral productivity and tumorigenesis. In Specific Aim 1, he will
quantify HPV16 lifecycle stages and tumourigenicity in tonsillar crypt and surface epithelia. In Specific Aim 2, he
will modulate PPARα activity to determine if it controls viral productivity and tumorigenicity. In the R00
independent phase, in Specific Aim 3, Dr. Jackson will establish his independent research program and define
the spatiotemporal viral-host transcriptome across oropharyngeal tissues. The proposed mentored research will
be performed at the University of Arizona, an ideal research and training environment, and will be coupled with
a career development plan including structured professional development and new techniques training. Dr.
Jackson will be supported by his primary mentor, Dr. Koenraad Van Doorslaer, as well as an advisory committee
that will ensure his successful transition to a tenure-track faculty position for the independent phase. Dr.
Jackson’s proposed research aligns with the NIDCR’s strategic priority to integrate oral and general health, with
an objective to advance prevention, early detection, and treatments for head and neck cancers using the tactic
of characterizing HPV+ oropharyngeal cancers. Dr. Jackson’s research is relevant as it intersects with notices
of special interest including single-cell level spatiotemporal mapping of oral tissue and incorporates
computational approaches.
Public Health Relevance Statement
Project Narrative
Human papillomavirus (HPV) causes 5% of cancers worldwide, including a growing number of oral
cancers. In the United States, HPV-associated oral cancers, most often arising in the tonsils, are considered an
epidemic but are poorly understood. To contribute to fundamental knowledge and address the oral health burden
caused by HPV, this project will determine the host factors regulating oral HPV infection and carcinogenesis
using three-dimensional epithelial models and computational approaches.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
806345617
UEI
ED44Y3W6P7B9
Project Start Date
01-September-2024
Project End Date
31-August-2026
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$118,763
Direct Costs
$109,966
Indirect Costs
$8,797
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Dental and Craniofacial Research
$118,763
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1K99DE033483-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1K99DE033483-01
Patents
No Patents information available for 1K99DE033483-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1K99DE033483-01
Clinical Studies
No Clinical Studies information available for 1K99DE033483-01
News and More
Related News Releases
No news release information available for 1K99DE033483-01
History
No Historical information available for 1K99DE033483-01
Similar Projects
No Similar Projects information available for 1K99DE033483-01